环指E3结合酶,RNF138通过负面调节Runx2蛋白周转率来抑制骨质细胞分化
Vishal Upadhyay1,2, Anil Kumar Singh1,2, Shivani Sharma2,3
1Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Utter Pradesh, India.
Journal of cellular physiology
|February 8, 2024
概括
RNF138的乌比奎丁结合酶向Runx2,这是骨形成的关键因素. 抑制RNF138可以增强Runx2和骨生长,这表明RNF138是骨质疏松症的治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 骨生物学 骨生物学 骨生物学
背景情况:
- Runx2是骨形成的关键转录因子,在多个层面上受到调节.
- 乌比基连酶通过乌比基-蛋白酶体系统在蛋白质循环和细胞过程中发挥作用.
- RNF138,一个真正有趣的新基因 (RING) 指基因酶,与调节蛋白质稳定性有关.
研究的目的:
- 研究RNF138在调节Runx2蛋白水平和骨质母细胞分化中的作用.
- 探索RNF138作为骨质疏松症治疗点的潜力.
主要方法:
- 在骨质疏松性大鼠中,对RNF138和Runx2蛋白水平的相关性分析.
- 使用C3H10T1/2和初级大鼠骨细胞 (RCO) 的体外研究来评估RNF138过度表达和耗尽对骨质细胞分化的影响.
- 通过RNF138调节Runx2的机制的研究,包括物理关联,无化和蛋白质体降解.
主要成果:
- RNF138与骨质疏松性大鼠的Runx2蛋白水平有负相关性,这表明它在骨质损失中的作用.
- 过度表达RNF138抑制了骨质母细胞分化,而减少RNF138则通过增加Runx2水平来增强它.
- RNF138直接无处不在Runx2,导致其蛋白质体降解和蛋白质稳定性降低,从而抑制骨质细胞分化和功能.
结论:
- RNF138通过促进Runx2通过ubiquitin-proteasome通路的降解来负面调节骨的形成.
- RNF138是Runx2稳定性和骨质生成活性的一个关键调节器.
- RNF138代表了治疗绝经后骨质疏松症的潜在治疗标.
相关概念视频
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


